NLRP3 and cryopyrin-associated periodic syndrome: CY-09 is also an inhibitor of NLRP3 inflammasome potentially used for osteoarthritis, cryopyrin-associated autoinflammatory syndrome (CAPS) and type 2 diabetes (Jiang et al., 2017; Zhang, Y. et al., 2021).